Zosano Pharma to Present at the H.C. Wainwright Global Life Sciences Conference
Zosano Pharma Corporation (NASDAQ:ZSAN) will present a company overview by its president and CEO, Steven Lo, at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, at 7:00 am ET. The presentation will be accessible via a webcast on the company’s website, and an archived version will be available for 30 days post-event.
Zosano focuses on transdermal microneedle technology for rapid drug delivery, with its lead product candidate, Qtrypta™ (M207), aimed at treating migraines.
- None.
- None.
FREMONT, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, Steven Lo, will present a company overview at the H.C. Wainwright Global Life Sciences Conference which will be available on Tuesday, March 9, 2021 at 7:00 am ET.
A webcast of the event will be available on the company’s website at http://ir.zosanopharma.com/events-presentations. The archived webcast will remain available for 30 days following the date of the presentation.
About Zosano Pharma
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company’s transdermal microneedle system technology consists of titanium microneedles coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano’s lead product candidate is Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine. Learn more at www.zosanopharma.com.
Zosano Contacts:
Christine Matthews
Chief Financial Officer
510-745-1200
Zosano PR:
Sylvia Wheeler or Alexandra Santos
swheeler@wheelhouselsa.com or asantos@wheelhouselsa.com
FAQ
When will Zosano Pharma present at the H.C. Wainwright Global Life Sciences Conference?
How can I access Zosano Pharma's presentation at the conference?
What is the lead product candidate of Zosano Pharma?
What technology does Zosano Pharma use for drug delivery?
How long will the archived webcast of Zosano Pharma's presentation be available?
